Other group of compounds studied for their anti-dengue activities include novel thiadiazoloacrylamide analogues with one of these showing moderate activity with IC50 values at 2.2 μM based on NS2B/NS3 protease assay [56]. This evidence concerns the gene KRAS and dengue disease.